Evidence map›Paper›PMID 30597050›Full record

ArticleThe Journal of infectious diseases2019

Failure of Cytomegalovirus-Specific CD8+ T Cell Levels at Viral DNAemia Onset to Predict the Eventual Need for Preemptive Antiviral Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Estela Giménez, Carlos Solano, José Luis Piñana, Marc Poch, Eva Mateo, Eliseo Albert, Juan Carlos Hernández-Boluda, Paula Amat, María José Remigia, Ariadna Pérez and 1 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Estela GiménezMicrobiology, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Carlos SolanoHematology Services, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
José Luis PiñanaHematology Services, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Marc PochHematology Services, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Eva MateoMicrobiology, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Eliseo AlbertMicrobiology, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Juan Carlos Hernández-BoludaHematology Services, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Paula AmatHematology Services, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
María José RemigiaHematology Services, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
Ariadna PérezHematology Services, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.
David NavarroMicrobiology, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationCD8-Positive T-LymphocytesCytomegalovirusEnzyme-Linked Immunospot AssayHumansTransplant RecipientsAntiviral Agentsallogeneic hematopoietic stem cell transplantation (allo-HSCT)CMV DNAemiaCMV-specific CD8+ T cellsCytomegalovirus (CMV)immunological monitoringpreemptive antiviral therapy

Identifiers

PMID30597050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.